ChemSpider 2D Image | Preladenant | C25H29N9O3

Preladenant

  • Molecular FormulaC25H29N9O3
  • Average mass503.556 Da
  • Monoisotopic mass503.239349 Da
  • ChemSpider ID8293510

More details:

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

2-(2-Furyl)-7-(2-{4-[4-(2-methoxyethoxy)phenyl]-1-piperazinyl}ethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amin [German] [ACD/IUPAC Name]
2-(2-Furyl)-7-(2-{4-[4-(2-methoxyethoxy)phenyl]-1-piperazinyl}ethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine [ACD/IUPAC Name]
2-(2-Furyl)-7-(2-{4-[4-(2-méthoxyéthoxy)phényl]-1-pipérazinyl}éthyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine [French] [ACD/IUPAC Name]
2-(furan-2-yl)-7-(2-{4-[4-(2-methoxyethoxy)phenyl]piperazin-1-yl}ethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine
377727-87-2 [RN]
7H-Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine, 2-(2-furanyl)-7-[2-[4-[4-(2-methoxyethoxy)phenyl]-1-piperazinyl]ethyl]- [ACD/Index Name]
preladenant [Spanish] [INN]
Preladenant [INN] [USAN] [Wiki]
préladénant [French] [INN]
preladenantum [Latin] [INN]
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

8880 [DBID]
950O97NUPO [DBID]
Sch 420814 [DBID]
SCH-420814 [DBID]
UNII:950O97NUPO [DBID]
Unii-950o97nupo [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous

    • Bio Activity:

      Adenosine Receptor MedChem Express HY-10889
      GPCR/G protein MedChem Express HY-10889
      GPCR/G protein; MedChem Express HY-10889
      Preladenant (SCH 420814) is a potent and selective antagonist at the adenosine A2A receptor. MedChem Express http://www.medchemexpress.com/sb-334867.html, HY-10889
      Preladenant (SCH 420814) is a potent and selective antagonist at the adenosine A2A receptor. ;IC50 value:;Target: adenosine A2A receptor;The adenosine A(2A) receptor has been implicated in the underlying biology of various neurological and psychiatric disorders, including Parkinson's disease (PD) and depression. Preladenant is being researched as a potential treatment for Parkinson's disease. Positive results were reported in Phase II clinical trials in humans. MedChem Express HY-10889

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

Density: 1.5±0.1 g/cm3
Boiling Point:
Vapour Pressure:
Enthalpy of Vaporization:
Flash Point:
Index of Refraction: 1.733
Molar Refractivity: 136.4±0.5 cm3
#H bond acceptors: 12
#H bond donors: 2
#Freely Rotating Bonds: 9
#Rule of 5 Violations: 2
ACD/LogP: 1.45
ACD/LogD (pH 5.5): 0.07
ACD/BCF (pH 5.5): 1.00
ACD/KOC (pH 5.5): 7.70
ACD/LogD (pH 7.4): 1.16
ACD/BCF (pH 7.4): 4.32
ACD/KOC (pH 7.4): 94.72
Polar Surface Area: 125 Å2
Polarizability: 54.1±0.5 10-24cm3
Surface Tension: 63.9±7.0 dyne/cm
Molar Volume: 340.8±7.0 cm3

Click to predict properties on the Chemicalize site


Advertisement